Table 2.
SPARC | VEGF | MVD( |
Ki-67( |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
parameters | n | high | low | P | (+) (−) | P | P | P | ||
age | ||||||||||
<50 | 12 | 7 | 5 | 0.531 | 10 2 | 0.175 | 45.33 ± 15.92 | 0.980 | 24.76 ± 8.30 | 0.446 |
≥50 | 68 | 33 | 35 | 43 25 | 45.23 ± 12.12 | 26.82 ± 8.64 | ||||
gender | ||||||||||
male | 59 | 28 | 31 | 0.446 | 37 22 | 0.262 | 45.76 ± 12.44 | 0.547 | 27.49 ± 8.48 | 0.086 |
female | 21 | 12 | 9 | 16 5 | 43.80 ± 13.42 | 23.75 ± 8.40 | ||||
Laurentype | ||||||||||
intestinal | 38 | 24 | 14 | 0.025 | 18 20 | 0.001 | 38.71 ± 9.21 | 0.000 | 25.66 ± 8.90 | 0.402 |
diffuse | 42 | 16 | 36 | 35 7 | 51.17 ± 12.50 | 27.28 ± 8.29 | ||||
differentiation | ||||||||||
high | 41 | 28 | 13 | 0.001 | 21 20 | 0.004 | 39.29 ± 9.06 | 0.000 | 25.19 ± 8.01 | 0.157 |
low | 39 | 12 | 27 | 32 7 | 51.51 ± 12.95 | 27.91 ± 9.01 | ||||
stage | ||||||||||
I–II | 41 | 26 | 15 | 0.014 | 23 18 | 0.049 | 38.76 ± 7.05 | 0.000 | 23.86 ± 8.52 | 0.004 |
III–IV | 39 | 14 | 25 | 30 9 | 52.08 ± 13.68 | 29.30 ± 7.79 | ||||
Tumor | ||||||||||
T4 | 50 | 24 | 26 | 0.644 | 35 15 | 0.360 | 48.98 ± 13.40 | 0.000 | 28.52 ± 7.77 | 0.001 |
T1-T3 | 30 | 16 | 14 | 18 12 | 39.03 ± 8.30 | 23.16 ± 8.91 | ||||
LN | ||||||||||
N1-N3 | 48 | 18 | 30 | 0.006 | 36 12 | 0.043 | 49.94 ± 13.70 | 0.000 | 28.49 ± 8.29 | 0.010 |
N0 | 32 | 22 | 10 | 17 15 | 38.22 ± 6.21 | 23.54 ± 8.23 |